Your browser doesn't support javascript.
loading
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.
Nakahara, Yoshiro; Shimokawa, Tsuneo; Misumi, Yuki; Nogami, Naoyuki; Shinkai, Tetsu; Seki, Nobuhiko; Hosomi, Yukio; Hida, Naoya; Okamoto, Hiroaki.
Afiliação
  • Nakahara Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, 3-18-22, Honkomagome, Bunkyo-ku, Tokyo, 113-8677, Japan. md100062@kcch.jp.
  • Shimokawa T; Department of Respiratory Medicine, Kitasato University School of Medicine, 1-15-1, Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. md100062@kcch.jp.
  • Misumi Y; Department of Thoracic Oncology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan. md100062@kcch.jp.
  • Nogami N; Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Kanagawa, 240-8555, Japan.
  • Shinkai T; Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, Kanagawa, 240-8555, Japan.
  • Seki N; Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan.
  • Hosomi Y; Department of Thoracic Oncology, National Hospital Organization Shikoku Cancer Center, 160 Kou Minami-Umemoto, Matsuyama, Ehime, 791-0280, Japan.
  • Hida N; Department of Medical Oncology, Shonan Eastern General Hospital, 500, Nishikubo, Chigasaki, Kanagawa, 253-0083, Japan.
  • Okamoto H; Division of Medical Oncology, Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-0014, Japan.
Invest New Drugs ; 39(1): 202-209, 2021 02.
Article em En | MEDLINE | ID: mdl-32803700

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Tegafur / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Tegafur / Carcinoma Pulmonar de Células não Pequenas / Cloridrato de Erlotinib / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão